---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-23-000126"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2023-12-27T23:59:59+00:00"
generated_at: "2026-06-07T06:58:12.913349+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints Terrence Ronan as Interim CFO effective Jan 27, 2024

## Summary
- Ronan will join as Interim SVP of Finance on Jan 2, 2024, then become Interim CFO on Jan 27, 2024 after Scott Leffler's departure.
- Ronan is a certified public accountant (inactive) with prior CFO roles at Purdue Pharma L.P. and Atlantic Power Corporation.
- Company will pay AP Services, LLC (AlixPartners subsidiary) a monthly fee of $195,000 for Ronan's services as Interim CFO.
- No family relationships or material interests in transactions disclosed between Ronan and any director or executive officer.

## SEC filing metadata
- accession: 0001801170-23-000126
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2023-12-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/0001801170-23-000126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/clov-20231222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-23-000126
- JSON: https://secwatch.observer/filing/0001801170-23-000126.json
- Plain text: https://secwatch.observer/filing/0001801170-23-000126.txt

## Key facts
- Executive change
  Scott J. Leffler departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: departure
  - Role: Chief Financial Officer
  source text: following Scott J. Leffler’s previously announced departure as Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/0001801170-23-000126-index.htm
- Executive change
  Terrence Ronan was appointed as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On December 22, 2023, the Board of Directors of Clover Health Investments, Corp. (the “Company”) appointed Mr. Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000126/0001801170-23-000126-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.